Prognosis in Head and Neck Cancer: Importance of Nutritional and Biological Inflammatory Status.


Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 14 4 2021
medline: 22 2 2022
entrez: 13 4 2021
Statut: ppublish

Résumé

To determine the importance of nutritional status, social status, and inflammatory status in the prognosis of head and neck cancer. Single-center retrospective study of prospectively collected data. Tertiary referral center. Ninety-two consecutive patients newly diagnosed for cancer of the upper aerodigestive tract without metastases were assessed at time of diagnosis for several prognostic factors. Nutritional status was assessed by the nutritional risk index, social status by the EPICES score, and inflammatory status by the systemic inflammatory response index. The primary endpoint was overall survival. In multivariable analysis, the main prognostic factors were the TNM classification (hazard ratio [HR] = 3.34, Prognosis in head and neck cancer is multifactorial; however, malnutrition and inflammation are important factors that are potentially reversible by early intervention.

Identifiants

pubmed: 33845660
doi: 10.1177/01945998211004592
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-127

Auteurs

Nicolas Saroul (N)

Otolaryngology-Head and Neck Surgery Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Mathilde Puechmaille (M)

Otolaryngology-Head and Neck Surgery Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Céline Lambert (C)

Biostatistics Unit (DRCI), Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Achraf Sayed Hassan (AS)

Otolaryngology-Head and Neck Surgery Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Julian Biau (J)

Radiation Oncology Department, Centre Jean Perrin, Clermont-Ferrand, France.

Michel Lapeyre (M)

Radiation Oncology Department, Centre Jean Perrin, Clermont-Ferrand, France.

Thierry Mom (T)

Otolaryngology-Head and Neck Surgery Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Maureen Bernadach (M)

Medical Oncology Department, Centre Jean Perrin, Clermont-Ferrand, France.

Laurent Gilain (L)

Otolaryngology-Head and Neck Surgery Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH